Andrew E. Massey

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Murali Mohan Yallapu · 3 shared papers, 2019–2020 · strength 0.33
   • Paper Biophysical changes caused by altered MUC13 expression in pancreatic cancer cells. DOI 10.1016/j.micron.2019.102822↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
2. Subhash C. Chauhan · 3 shared papers, 2019–2020 · strength 0.33
   • Paper Biophysical changes caused by altered MUC13 expression in pancreatic cancer cells. DOI 10.1016/j.micron.2019.102822↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
3. Bilal Bin Hafeez · 2 shared papers, 2019 · strength 0.17
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
4. Meena Jaggi · 2 shared papers, 2019 · strength 0.17
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
5. Sonam Kumari · 2 shared papers, 2019 · strength 0.17
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
6. Saini Setua · 2 shared papers, 2019 · strength 0.17
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
7. Sheema Khan · 2 shared papers, 2019 · strength 0.17
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
8. Mohammed Sikander · 1 shared paper, 2019 · strength 0.08
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
9. Neeraj Chauhan · 1 shared paper, 2019 · strength 0.08
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
10. Advait B. Shetty · 1 shared paper, 2019 · strength 0.08
    • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
11. Vivek Kumar Kashyap · 1 shared paper, 2019 · strength 0.08
    • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
12. Zachary E. Stiles · 1 shared paper, 2019 · strength 0.08
    • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
13. Stephen W. Behrman · 1 shared paper, 2019 · strength 0.08
    • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.